← Open Payments lookup

DONALD SMITH: Open Payments

NPI 1952388035 · RICHMOND, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$731 in 33 payments from 17 companies in 2025. Trend: 2023 $429 · 2024 $548 · 2025 $731

Food & beverage: $681Long term medical supply or device loan: $50
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)8$154
Eisai Inc.3$111
Abbott Laboratories3$78
Lilly USA, LLC3$55
Teva Pharmaceuticals USA, Inc.2$53
Vanda Pharmaceuticals Inc.2$52
JAZZ PHARMACEUTICALS INC.1$38
PFIZER INC.2$29
Aimmune Therapeutics, Inc.1$24
Smith+Nephew, Inc.1$22

Products named: CAPLYTA, Leqembi, AUSTEDO XR, FANAPT, FREESTYLE INSULINX, MOUNJARO, XYWAV, FREESTYLE LIBRE 3.

Industry payments across IN — which companies pay providers there.